Inovio Pharma (INO) Tops Q2 EPS by 19c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.24 --0%
EPS Growth %: +75.9%
Financial Fact:
Loss from operations: -20.2M
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: +75.9%
Financial Fact:
Loss from operations: -20.2M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q2 EPS of $, $0.19 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $20.4 million versus the consensus estimate of $16.29 million.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- HP shares slide as tech giant forecasts 2027 PC market slump
- Credo Technology shares rise on analyst support and conference comments
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
